Kennedy Trust for Rheumatology Research v Hospira Healthcare Corporation

Call to arrange a consultation

2018

A-360-18

Resolved

Biosimilars

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Counsel to:

Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd., Celltrion Inc. and Pfizer Canada Inc.

The decision is reported

Partner